Literature DB >> 4052366

Effect of praziquantel on intraocular cysticercosis: a case report.

P Kestelyn, H Taelman.   

Abstract

A patient with intravitreous cysticercosis was treated with the new anthelminthic drug, praziquantel. A transient toxic effect on the cysticerus was observed, but the drug was unable to kill the parasite.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4052366      PMCID: PMC1040740          DOI: 10.1136/bjo.69.10.788

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

1.  Failure of medical treatment in two cases of of intraocular cysticercosis.

Authors:  R Santos; M Chavarria; A E Aguirre
Journal:  Am J Ophthalmol       Date:  1984-02       Impact factor: 5.258

2.  [A case of successfully treated cerebral cysticercosis].

Authors:  C Robles; M Chavarría
Journal:  Gac Med Mex       Date:  1980-02       Impact factor: 0.302

3.  Therapy of parenchymal brain cysticercosis with praziquantel.

Authors:  J Sotelo; F Escobedo; J Rodriguez-Carbajal; B Torres; F Rubio-Donnadieu
Journal:  N Engl J Med       Date:  1984-04-19       Impact factor: 91.245

4.  Management of subretinal and vitreous cysticercosis: role of photocoagulation and surgery.

Authors:  R Santos; A Dalma; E Ortiz; L Sanchez-Bulnes
Journal:  Ophthalmology       Date:  1979-08       Impact factor: 12.079

5.  Cerebral cysticercosis: treatment with praziquantel. Report of two cases.

Authors:  K Markwalder; K Hess; A Valavanis; F Witassek
Journal:  Am J Trop Med Hyg       Date:  1984-03       Impact factor: 2.345

6.  Praziquantel: a major advance in anthelminthic therapy.

Authors:  R D Pearson; R L Guerrant
Journal:  Ann Intern Med       Date:  1983-08       Impact factor: 25.391

7.  Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel.

Authors:  L D deGhetaldi; R M Norman; A W Douville
Journal:  Ann Intern Med       Date:  1983-08       Impact factor: 25.391

8.  Removal of intravitreous cysticerci from the surface of the optic nervehead. A pars plana approach.

Authors:  K M Zinn; S L Guillory; A H Friedman
Journal:  Arch Ophthalmol       Date:  1980-04

9.  Administration of praziquantel in neurocysticercosis.

Authors:  A Spina-França; J P Nobrega; J A Livramento; L R Machado
Journal:  Tropenmed Parasitol       Date:  1982-03
  9 in total
  4 in total

1.  Oral albendazole in the management of extraocular cysticercosis.

Authors:  R Sihota; S G Honavar
Journal:  Br J Ophthalmol       Date:  1994-08       Impact factor: 4.638

2.  Infestation of extraocular muscle by Cysticercus cellulosae.

Authors:  D A DiLoreto; R A Kennedy; J M Neigel; J Rootman
Journal:  Br J Ophthalmol       Date:  1990-12       Impact factor: 4.638

3.  Experimental intravitreous cysticercosis.

Authors:  A Santos; J A Paczka; J M Jiménez-Sierra; P Chévez; C Velasco; A Flisser; H Quiroz-Mercado
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

4.  In-toto removal of a subretinal Cysticercus cellulosae by pars plana vitrectomy.

Authors:  M H Luger; J S Stilma; P J Ringens; J van Baarlen
Journal:  Br J Ophthalmol       Date:  1991-09       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.